Venessa Chin - Concepedia

Author

Venessa Chin

Garvan Institute of Medical Research ORCID

Also Known As

Angela Chou, Chin, Venessa, Elizabeth A. Musgrove, J L Humphris, Lorraine A. Chantrill, Rachel Wong, V Chin, V. Chin, V., Chin, V.T. Chin

107

Publications

12.4K

Citations

H-Index

Concepts

All Affiliations

Garvan Institute of Medical Research The University of Sydney UNSW Sydney The Kinghorn Cancer Centre St Vincent's Hospital Sydney

About

Venessa Chin is an author at Garvan Institute of Medical Research specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	3.9K
2	Cell Biology	2	2	89
3	Natural Sciences	1	1	25
4	Molecular Biology	1	1	25
5	Molecular Medicine	1	1	25

Venessa Chin

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Genomic analyses identify molecular subtypes of pancreatic cancer Peter J. Bailey, David K. Chang, Kátia Nones, Nature Pancreatic CancerMedicinePathologyCancer GenomicsMolecular Diagnostics	2016	3.6K
The prognostic and predictive value of serum CA19.9 in pancreatic cancer Jeremy L. Humphris, David K. Chang, Amber L. Johns, Annals of Oncology	2012	290
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis Claire Vennin, Venessa Chin, Sean Warren, Science Translational Medicine	2017	262
Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial Lorraine A. Chantrill, Adnan Nagrial, Clare Watson, Clinical Cancer Research	2015	234
Hypermutation In Pancreatic Cancer Jeremy L. Humphris, Ann‐Marie Patch, Kátia Nones, Gastroenterology Pancreatic CancerPathologyMedicineCancer ResearchTumor Biology	2016	203
Histomolecular Phenotypes and Outcome in Adenocarcinoma of the Ampulla of Vater David K. Chang, Nigel B. Jamieson, Amber L. Johns, Journal of Clinical Oncology	2013	175
Clinical and molecular characterization of HER2amplified-pancreatic cancer Angela Chou, Nicola Waddell, Mark J. Cowley, Genome Medicine	2013	117
Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer Angela Chou, Danielle Froio, Adnan Nagrial, Gut	2017	117
Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study Luis Paz‐Ares, Óscar Juan, Giannis Mountzios, Journal of Clinical Oncology	2024	91
MASTL overexpression promotes chromosome instability and metastasis in breast cancer Samuel Rogers, Rachael A. McCloy, Benjamin L. Parker, Oncogene Breast OncologyP38 KinasePathologyCell DeathMastl Kinase	2018	64

Page 1